Armata Pharmaceuticals, Inc.
SEC 4 · Filed
0001104659-26-026583Accepted
Applies to the EDGAR acceptance time.
Other time zone
Insider transactionsEvent date Mar 9, 2026
Grant, award or other acquisition by Odysseas Kostas D
- Security
- Stock Options (Right to Buy)
- Shares
-
25,640
- Price per share
-
0.00
Structured facts
{
"code": "A",
"date": "2026-03-09",
"direction": "A",
"exercise_price": "11.61",
"expiration": "2036-03-09",
"footnotes": {
"F1": "The Stock Options will vest in full on March 9, 2027, subject to continuous service through the vesting date."
},
"owners": [
{
"cik": "0001483080",
"name": "Odysseas Kostas D",
"roles": [
"director"
],
"title": null
}
],
"ownership": "D",
"post_shares": "25640",
"price": "0.00",
"row": 1,
"rule_10b5_1": "0",
"security": "Stock Options (Right to Buy)",
"shares": "25640",
"table": "II",
"underlying_security": "Common Stock",
"underlying_shares": "25640"
}